Revenue for the Medical Research industry is expected to grow at an annualized 7.0% over the five years through 2023, to $17.8 billion. This includes an 6.4% increase in 2023. Revenue growth has been steadily slowing in recent years as the industry has matured, and competition for government funds and private funds has increased. Over half of the industry's revenue is derived from government funding. The Medical Research industry in China undertakes basic and applied research and development in the medical and pharmaceutical fields. Enterprises include laboratories of medical research institutes, medical schools and biotech firms.
The following research functions are not included in the industry: R&D activities by pharmaceutical or medical equipment manufacturing industries, research unrelated to the human body or human diseases, and the commercialization of medical research. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
The following research functions are not included in the industry: R&D activities by pharmaceutical or medical equipment manufacturing industries, research unrelated to the human body or human diseases, and the commercialization of medical research. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
ABOUT THIS INDUSTRY- Industry Definition
- Main Activities
- Similar Industries
- Additional Resources
- Executive Summary
- Key External Drivers
- Current Performance
- Industry Outlook
- Industry Life Cycle
- Supply Chain
- Products & Services
- Demand Determinants
- Major Markets
- International Trade
- Business Locations
- Market Share Concentration
- Key Success Factors
- Cost Structure Benchmarks
- Basis of Competition
- Barriers to Entry
- Industry Globalization
OPERATING CONDITIONS
- Capital Intensity
- Technology & Systems
- Revenue Volatility
- Regulation & Policy
- Industry Assistance
- Industry Data
- Annual Change
- Key Ratios
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Chinese Academy of Sciences
- WuXi AppTec Co., Ltd.
- Academy of Military Medical Sciences
- China Academy of Chinese Medical Sciences
- China State Institute of Pharmaceutical Industry Co., Ltd.
